{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T22:20:23Z","timestamp":1648938023749},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","revespcardiol.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.rec.2016.02.027","type":"journal-article","created":{"date-parts":[[2016,6,12]],"date-time":"2016-06-12T10:24:32Z","timestamp":1465727072000},"page":"923-930","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Extracellular Volume Detects Amyloidotic Cardiomyopathy and Correlates With Neurological Impairment in Transthyretin-familial Amyloidosis"],"prefix":"10.1016","volume":"69","author":[{"given":"Mar\u00eda","family":"Gallego-Delgado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Gonz\u00e1lez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Mu\u00f1oz-Beamud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Buades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"Gal\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Luis","family":"Mu\u00f1oz-Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"S\u00e1nchez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borja","family":"Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesus G.","family":"Mirelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Garc\u00eda-Pav\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2016.02.027_bib0175","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","article-title":"Familial amyloid polyneuropathy","volume":"10","author":"Plant\u00e9-Bordeneuve","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.rec.2016.02.027_bib0180","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg","year":"2012","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2016.02.027_bib0185","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1136\/heartjnl-2012-301924","article-title":"Cardiac transthyretin amyloidosis","volume":"98","author":"Dungu","year":"2012","journal-title":"Heart."},{"key":"10.1016\/j.rec.2016.02.027_bib0190","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.recesp.2011.05.003","article-title":"Amyloidosis. Also a Heart Disease","volume":"64","author":"Garc\u00eda-Pav\u00eda","year":"2011","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.rec.2016.02.027_bib0195","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/TP.0000000000000574","article-title":"Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?","volume":"99","author":"Ericzon","year":"2015","journal-title":"Transplantation."},{"key":"10.1016\/j.rec.2016.02.027_bib0200","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial","volume":"79","author":"Coelho","year":"2012","journal-title":"Neurology."},{"key":"10.1016\/j.rec.2016.02.027_bib0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10741-014-9462-7","article-title":"Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs","volume":"20","author":"Casta\u00f1o","year":"2015","journal-title":"Heart Fail Rev."},{"key":"10.1016\/j.rec.2016.02.027_bib0210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-8-31","article-title":"Guideline of transthyretin-related hereditary amyloidosis for clinicians","volume":"8","author":"Ando","year":"2013","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.rec.2016.02.027_bib0215","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.medcli.2015.02.003","article-title":"Recommendations regarding diagnosis and treatment of transthyretin Familial amyloid polyneuropathy","volume":"145","author":"Garc\u00eda-Pav\u00eda","year":"2015","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.rec.2016.02.027_bib0220","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/13506129.2013.825240","article-title":"Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosis","volume":"20","author":"Damy","year":"2013","journal-title":"Amyloid."},{"key":"10.1016\/j.rec.2016.02.027_bib0225","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCIMAGING.113.001396","article-title":"How to Image Cardiac Amyloidosis","volume":"7","author":"Falk","year":"2014","journal-title":"Circ Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2016.02.027_bib0230","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCULATIONAHA.109.930636","article-title":"Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans","volume":"122","author":"Flett","year":"2010","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2016.02.027_bib0235","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/heartjnl-2012-302346","article-title":"Cardiovascular Magnetic Resonance Measurement of Myocardial Extracellular Volume in Health and Disease","volume":"98","author":"Sado","year":"2012","journal-title":"Heart."},{"key":"10.1016\/j.rec.2016.02.027_bib0240","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/CIRCIMAGING.112.973438","article-title":"T1 mapping shows increased extracellular matrix size in the myocardium due to amyloid depositions","volume":"5","author":"Robbers","year":"2012","journal-title":"Circ Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2016.02.027_bib0245","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","article-title":"Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome","volume":"21","author":"Freeman","year":"2011","journal-title":"Clin Auton Res."},{"key":"10.1016\/j.rec.2016.02.027_bib0250","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1212\/WNL.49.1.229","article-title":"Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort","volume":"49","author":"Dyck","year":"1997","journal-title":"Neurology."},{"key":"10.1016\/j.rec.2016.02.027_bib0255","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/dia.2005.7.497","article-title":"The development and validation of the Norfolk QOL-DN, a new measure of patients\u2019 perception of the effects of diabetes and diabetic neuropathy","volume":"7","author":"Vinik","year":"2005","journal-title":"Diabetes Technol Ther."},{"key":"10.1016\/j.rec.2016.02.027_bib0260","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L","article-title":"The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma","volume":"1","author":"Karnofsky","year":"1948","journal-title":"Cancer."},{"key":"10.1016\/j.rec.2016.02.027_bib0265","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2016.02.027_bib0270","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","article-title":"Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis","volume":"3","author":"Syed","year":"2010","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2016.02.027_bib0275","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1532-429X-15-35","article-title":"Standardized image interpretation and post processing in cardiovascular magnetic resonance","volume":"15","author":"Schulz-Menger","year":"2013","journal-title":"J Cardiovasc Magn Reson."},{"key":"10.1016\/j.rec.2016.02.027_bib0280","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mrm.20110","article-title":"Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart","volume":"52","author":"Messroghli","year":"2004","journal-title":"Magn Reson Medicine."},{"key":"10.1016\/j.rec.2016.02.027_bib0285","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.recesp.2010.10.018","article-title":"Familial approach in hereditary transthyretin cardiac amyloidosis","volume":"64","author":"Garcia-Pavia","year":"2011","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2016.02.027_bib0290","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/mus.10320","article-title":"Individual attributes versus composite scores of nerve conduction abnormality: sensitivity, reproducibility, and concordance with impairment","volume":"27","author":"Dyck","year":"2003","journal-title":"Muscle Nerve."},{"key":"10.1016\/j.rec.2016.02.027_bib0295","first-page":"157","article-title":"Native T1 mapping in transthyretin amyloidosis","volume":"7","author":"Fontana","year":"2014","journal-title":"JACC: Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2016.02.027_bib0300","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","article-title":"Quantification of Myocardial Extracellular Volume Fraction in Systemic AL Amyloidosis: An Equilibrium Contrast Cardiovascular Magnetic Resonance Study","volume":"6","author":"Banypersad","year":"2013","journal-title":"Circ Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2016.02.027_bib0305","first-page":"488","article-title":"Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis","volume":"6","author":"Karamitsos","year":"2013","journal-title":"JACC: Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2016.02.027_bib0310","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","article-title":"T1 mapping and survival in systemic light-chain amyloidosis","volume":"36","author":"Banypersad","year":"2015","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2016.02.027_bib0315","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood-2004-01-0390","article-title":"Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation","volume":"104","author":"Dispenzieri","year":"2004","journal-title":"Blood."},{"key":"10.1016\/j.rec.2016.02.027_bib0320","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/eurheartj\/ehr383","article-title":"Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant","volume":"33","author":"Sattianayagam","year":"2012","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2016.02.027_bib0325","first-page":"502","article-title":"Noninvasive Risk Stratification of Patients With Transthyretin Amyloidosis","volume":"7","author":"Kristen","year":"2014","journal-title":"JACC: Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2016.02.027_bib0330","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.amjcard.2011.03.040","article-title":"Rate of Progression of Transthyretin Amyloidosis","volume":"108","author":"Benson","year":"2011","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rec.2016.02.027_bib0335","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/13506129.2013.787984","article-title":"Monitoring systemic amyloidosis using MRI measurements of the extracellular volume fraction","volume":"20","author":"Campbell-Washburn","year":"2013","journal-title":"Amyloid."},{"key":"10.1016\/j.rec.2016.02.027_bib0340","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12968-014-0069-x","article-title":"Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study","volume":"16","author":"Dabir","year":"2014","journal-title":"J Cardiovas Magn Reson."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585716300743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585716300743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T07:27:15Z","timestamp":1536650835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585716300743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1885585716300743"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2016.02.027","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular Volume Detects Amyloidotic Cardiomyopathy and Correlates With Neurological Impairment in Transthyretin-familial Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2016.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2016.05.011","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2016.02.032","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}